Global trade group taps Pfizer, Roche and Daiichi execs for 2-year stints on CEO leadership team

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) on Wednesday unveiled the upcoming lineup for its CEO leadership team over the next two years. Captaining the group as IFPMA’s new president and chair of the organization’s CEO steering committee will be Pfizer chief Albert Bourla. Beneath Bourla, Roche CEO Thomas Schinecker will act as IFPMA’s vice president alongside existing VP Sunao Manabe—the chief executive of Japanese drugmaker Daiichi Sankyo.